SCHEMBL8790388

SCHEMBL8790388

COc1ccc(CN(C)CCOc2ccc(N)c(C)c2)cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
BLM P54132 2/20 0.47
CYP2C9 P11712 1/20 0.47
MAPT P10636 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TSHR P16473 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
KCNH2 Q12809 1/20 0.44
PMP22 Q01453 1/20 0.44
ALDH1A1 P00352 3/20 0.44
AOC3 Q16853 1/20 0.43
ACHE P22303 2/20 0.41
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8789820 0.94 KDM4E (0.46) KDM4ECYP1A2CYP3A4CYP2D6BLM
SCHEMBL8790366 0.85 TSHR (0.53) KDM4ECYP1A2CYP3A4CYP2D6BLM
SCHEMBL8790671 0.84 KDM4E (0.48) KDM4ECYP1A2CYP3A4CYP2D6BLM
SCHEMBL8790592 0.83 CYP3A4 (0.64) KDM4ECYP1A2CYP3A4CYP2D6BLM
SCHEMBL8790572 0.81 ALDH1A1 (0.50) KDM4ECYP1A2CYP3A4CYP2D6BLM
SCHEMBL8791130 0.81 ALDH1A1 (0.54) KDM4ECYP1A2CYP3A4CYP2D6BLM
SCHEMBL8789780 0.81 KDM4E (0.45) KDM4ECYP1A2CYP3A4CYP2D6BLM
SCHEMBL8790500 0.79 CYP19A1 (0.51) KDM4ECYP1A2CYP3A4CYP2D6BLM
SCHEMBL8791027 0.76 NR1H3 (0.51) KDM4ECYP1A2CYP3A4CYP2D6BLM
SCHEMBL8790748 0.76 KCNH2 (0.50) KDM4ECYP1A2CYP3A4CYP2D6BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 US disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 EP disclosed